CTOs on the Move

Interim HealthCare

www.interimhealthcare.com

 
Interim HealthCare Inc., founded in 1966, is a leading national franchisor of home care, hospice and healthcare staffing. It is part of Caring Brands International which also includes UK-based Bluebird Care and Australia-based Just Better Care, both well-known franchise brands in their countries. With more than 530 franchise locations in seven countries Caring Brands International is a global health care leader. Interim HealthCare in the United States is unique in combining the commitment of local ownership with the support of a national organization that develops innovative programs and quality standards that improve the delivery of service. Franchisees employ ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $500M-1 Billion

Executives

Name Title Contact Details

Similar Companies

Essen Health Care

essen Health Care is a healthcare continuum in New York with over 300 providers across Manhattan, Bronx, Queens, Staten Island, Long Island and Westchester County. Essen is a patient focused integrated healthcare delivery platform with the goal of prov...

Voorhees Pediatric Facility

Voorhees Pediatric Facility is a Voorhees, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Canadian Dental Service Plans

Canadian Dental Service Plans Inc. is a North York, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

United Resource Networks

United Resource Networks is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Halberd Corporation

Halberd Corporation has acquired exclusive licenses to two issued patents and four provisional patent applications related to the extracorporeal treatment of blood-borne diseases and Cerebrospinal Fluid related diseases, with particular focus on the treatment and rapid detection of Covid-19 and other virus`. The issued patents` extracorporeal technology is applicable to a significant number of the most debilitating and often fatal illnesses affecting mankind: PTSD, CTE (Chronic Traumatic Encephalopathy) and Cancer, among others. We have developed an aggressive timetable to advance the development of these breakthrough technologies through laboratory, hospital, and clinical trials. In addition, we have initiated the development of potential patient trial application lists. Our management team has extensive experience and contacts in the medical/pharmaceutical fields as well as a demonstrated track record of launching new business ventures in a competitive environment.